Morgan Stanley Maintains Overweight on Corpay, Raises Price Target to $460

Benzinga · 10/28 18:03
Morgan Stanley analyst Michael Infante maintains Corpay (NYSE:CPAY) with a Overweight and raises the price target from $455 to $460.